Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin

Uncertainty regarding an optimal antiplatelet regimen still exists in patients with breakthrough acute ischemic stroke (AIS) while on aspirin. This study provides an analysis of a prospective multicenter registry between April 2008 and April 2014. Eligible patients were on aspirin at the time of AIS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Kim, Joon-Tae, Kim, Beom Joon, Park, Jong-Moo, Lee, Soo Joo, Cha, Jae-Kwan, Park, Tai Hwan, Lee, Kyung Bok, Lee, Jun, Hong, Keun-Sik, Lee, Byung-Chul, Kim, Dong-Eog, Choi, Jay Chol, Kwon, Jee-Hyun, Shin, Dong-Ick, Sohn, Sung Il, Lee, Ji Sung, Lee, Juneyoung, Bae, Hee-Joon
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541489/
https://ncbi.nlm.nih.gov/pubmed/33028887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73836-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky